Susan E. Quaggin - AbbVie Inc. Form 4 Filing

This SEC Form 4 filing details transactions by Susan E. Quaggin, a director at AbbVie Inc. (ABBV). On September 30, 2026, Quaggin acquired 59 Stock Equivalent Units (SEUs) with a transaction value of $261.59 per share, underlying AbbVie Common Stock. These SEUs were credited to an unfunded book account as director fees and will be distributed over her years of service, commencing at age 65 or retirement. The SEUs earn returns equivalent to AbbVie stock. Following this transaction, Quaggin holds 918 SEUs, which includes units acquired through dividend reinvestment. The filing was signed by T.O. Odutayo, Attorney-in-Fact for Susan E. Quaggin, on October 2, 2026.